Abstract
Diffuse interstitial lung disease (ILD) represents a heterogenous group of both acute and chronic disorders characterized by similar radiographic, clinical, and pathologic presentations. The differential diagnosis includes over 130 distinct clinicopathologic entities, thus making the diagnosis of ILD clinically challenging. Although little epidemiologic data is available, diffuse lung disease affects one in 3000–4000 people in Britain and results in 3000 deaths per year [1]. In the United States, pulmonologists encounter this diagnostic and management dilemma in nearly 15% of their patients [2]. Additionally, when less invasive measures are nondiagnostic, there is marked variability among practicing clinicians to pursue a specific diagnosis of ILD with open lung biopsy, ranging from 7.5% to 42% of patients with ILD [3,4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Office of Population (1991) London, HMSO DH2 No 17.
U.S. Department of Health, Education, and Welfare. Respiratory Task Force: Reports on problems, research, approaches, and needs. Washington DC: U.S. Government Printing Office; (1972, 1976) DHEW Publication. NIH 76–432.
Johnson I, Gomm S, Kalra A et al. (1993) The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Respir J 6: 891–3.
Smith C, Holbrook T (1990) Utilization of the transbronchial biopsy and open lung biopsy for tissue to establish the diagnosis of idiopathic pulmonary fibrosis: Survey of the California Thoracic Society Membership. Am Rev Respir Dis 141: 1762.
Raghu G (1987) Idiopathic pulmonary fibrosis: a rational clinical approach. Chest 92: 148–54.
Raghu G (1995) Interstitial Lung Disease: A Diagnostic Approach. Am J Respir Crit Care Med 151: 909–14.
Hunninghake G, Kalica A (1995) Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 151: 915–8.
Walters E, Booth H, Johns D; Walters, du Bois R, eds. (1995) Immunology and management of interstitial lung diseases. Chapman & Hall Medical, Great Britian.
du Bois R (1994) Diffuse Lung Disease: an approach to management. BMJ 309: 175–9.
Pue C, Pacht E (1995) Complications of fiberoptic bronchoscopy at a university hospital. Chest 107: 430–2.
Bokulic R, Hillman B (1994) Interstitial Lung Disease in Children. Ped Clin NA 41: 543–67.
Whitehead B, Scott J, Helms P et al. (1992) Technique and use of transbronchial biopsy in children and adolescents. Pediatr Pulmonol 12: 240–6.
Wall C, Gaensler E, Carrington C, Hayes J (1981) Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis 123: 280–5.
Zhang K, Phan S (1996) Cytokines and pulmonary fibrosis. Biological Signals 5: 232–9.
Carre P, Mortenson R, King T Jr et al. (1991) Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 88: 1802–10.
Nakamura H, Fujishima S, Yasuhiro W et al. (1995) Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 152: 1579–86.
Strieter R, Chensue S, Basha M et al. (1990) Human alveolar macrophage gene expression of interleukin- 8 by tumor necrosis factor alpha, lipopolysaccharide, and interleukin-1 beta. Am J Respir Cell Mol Biol 2: 321–6.
Hunninghake G (1984) Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev of Resp Dis 129: 569–72.
Perez T, Farre J, Gosset P et al. (1989) Subclinical alveolar inflammation in rheumatoid arthritis: superoxide anion, neutrophil chemotactic activity and fibronectin generation by alveolar macrophages. Eur Respir J 2: 7–13.
McDonald J (1992) Idiopathic pulmonary fibrosis. A paradigm for lung injury and repair. Chest 99: 87S–93S.
Springer T (1990) Adhesion receptors of the immune system. Nature 346: 425–34.
du Bois R, Hellewell P, Hemingway I etal. (1992) Soluble cell adhesion molecules ICAM-1, ELAM-1 and VCAM-1 are present in epithelial lining fluid in patients with interestitial lung disease. Am Rev Respir Dis 145: A190 (Abstr).
Shijubo N, Hirasawa M, Koba H etal. (1992) Measurement of circulating ICAM-1 in sera of patients with IPF. Am Rev Respir Dis 145: A189 (Abstr).
Reynolds H (1987) Bronchoalveolar lavage. Am Rev Respir Dis 135: 250–63.
von Essen S, Robbins R, Rennard S (1989) Airways inflammation after bronchoscopy with bronchoalveolar lavage. Am Rev Respir Dis 139: 381.
Iber C, Stanley M, Henry-Stanley M etal. (1991) Clinical aspects of bronchoalveolar lavage. Bronchoalveolar lavage: cytology and clinical applications; Igoku-Shoin, New York, pp. 1–25.
The BAL Cooperative Steering Committee (1990) Bronchoalveolar lavage constituents in healthy indi-viduals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 141 (suppl):l–200.
Henry-Stanley M, Stanley M, Iber C, Laboratory processing of BAL fluid. Bronchoalveolar lavage: cytology and clinical applications. Igoku-Shoin, New York; pp. 213–28.
Rankin J, Naegel G, Reynold H (1986) Use of a central laboratory for analysis of bronchoalveolar fluid. Am Rev Respir Dis 133: 186–90.
Chamberlain D, Braude A, Rebuck A (1987) A critical evaluation of bronchoalveolar lavage: Criteria for identifying unsatisfactory specimens. Acta Cyto 31: 599–605.
Davis G, Giancola M, Costanza M et al. (1982) Analyses of sequential bronchoalveolar lavage samples from healthy volunteers. Am Rev Respir Dis 126: 611–6.
Strumpf I, Feld M, Cornelius M et al. (1981) Safety of bronchoalveolar lavage in evaluation of interstitial lung disease. Chest 80: 268–71.
Pingleton S, Harrison G, Stechschulte D et al. (1983) Effect of location, pH, and temperature of instillate in bronchoalveolar lavage in normal volunteers. Am Rev of Resp Dis 128: 1035–7.
Turner-Warwick M, Haslam P (1987) The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir 135: 26–34.
Rudd R, Haslam P, Turner-Warwick M (1981) Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and diagnosis. Am Rev Respir Dis 124: 1–8.
DePaso W, Winterbauer R (1991). Interstitial lung disease. Disease-A-Month 37: 61–133.
Milman N, Graudal N, Jocobsen G (1995) Bronchoalveolar lavage in radiologically detected diffuse lung disease. APMIS 103: 764–8.
Drent M, van Nierop M, Gerritsen F, Wouters E, Mulder P (1996) A computer program using BALF- analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 153: 736–41.
Kantrow S, Meyer K, Calhoun W et al. (1994) The T helper suppressor ratio in bronchoalveolar lavage is highly variable in sarcoidosis. Am J Resp Crit Care Med 149: A606.
Birbeck M, Breathnach A, Everall J (1961) An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 37: 51–64.
Chollet S, Soler P, Dournovo et al. (1984) The diag-nosis of pulmonary histiocytosis X by immunodetection of Langerhan’s cells in BALF. Am J Pathol 37: 104–9.
Manganelli P, Salaffi F, Pesci A (1997) Clinical and subclinical alveolitis in connective tissue diseases assessed by bronchoalveolar lavage. Semin Arthritis Rheum 26: 740–54.
Spertini F, Aubert J, Leimgruber A (1996) The potential of bronchoalveolar lavage in the prognosis and treatment of connective-vascular disease. Clin Exp Rheumatol 14: 681–8.
Schnabel A, Richter C, Bauerfeind S et al. (1997) Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax 52: 377–9.
Sokolowski Jr J, Burgher L, Jones Jr F et al. (1989) Guidelines for Percutaneous Transthoracic Needle Biopsy. Am Rev Respir Dis 140: 255–6.
Steel S, Winstanley D (1967) Trephine Biopsy for Diffuse Lung Lesions. Br Med J 3: 30–2.
Golden J; Baum G, Wolinsky E. (1994) Interstitial (diffuse parenchymal) lung disease: tissue diagnosis and therapy. Textbook of Pulmonary Diseases. Little Brown; Boston, pp. 1067–95.
Niden A, Salem F (1997) A safe high-yield technique for cutting needle biopsy of the lung in patients with diffuse lung disease. Chest 111: 1615–21.
Gaensler E, Carrington C (1980) Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thor Surg 30: 411–26.
Wall C, Gaensler E, Carrington C et al. (1981) Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis 123: 280–5.
LoCicero J (1994) Does every patient with enigmatic lung disease deserve a lung biopsy? The continuing dilemma. Chest 106: 706–8.
Walker W, Cole F Jr, Khandekar A et al. (1989) Does open lung biopsy affect treatment in patients with diffuse pulmonary infiltrates? J Thorac Cardiovasc Surg 97: 534–40.
Warner D, Warner M, Divertie M (1988) Open lung biopsy in patients with diffuse pulmonary infiltrates and acute respiratory failure. Am Rev Respir Dis 137: 90–4.
Klassen K, Andrews N (1967) Biopsy of diffuse pul-monary lesions. Ann Thorac Surg 4: 117–24.
Flint A, Martinez F, Young M et al. (1995) Influence of sample number and biopsy site on the histologic diagnosis of diffuse lung disease. Ann Thorac Surg 60: 1605–8.
Chechani V, Landreneau R, Shaikh S (1992) Open lung biopsy for diffuse infiltrative lung disease. Ann Thorac Surg 54: 296–300.
Jacobeus H (1927) The practical importance of thoracoscopy in surgery of the chest. Surg Gynecol Obstet 34: 289–96.
McCarthy J, Hurberg J, Wood A (1997) The diverse potential of thoracoscopic assisted surgery. Int Surg 82: 29–31.
Ferson P (1993) Thoracoscopic wedge resection of the lung. Surgical Rounds, 16: 341–9.
Ferguson M (1993) Thoracoscopy for diagnosis of diffuse lung disease. Ann Thorac Surg 56: 694–6.
Molin L, Steinberg J, Lanza L (1994) VATS increases costs in patients undergoing lung biopsy for interstitial lung disease. Ann Thorac Surg 58: 1595–8.
Bensard D, Mclntyre Jr. R, Waring B et al. (1993) Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest 103: 765–70.
Rothenberg S, Wagner J, Chang J, et al. (1996) The safety and efficacy of thoracoscopic lung biopsy for diagnosis and treatment in infants and children. J Pediatr Surg 31: 100–3.
Deshmukh S, Krasna M, McLaughlin J (1996) Video- assisted thoracoscopic biopsy for interstitial lung disease. Int Surg 81: 330–2.
Ferson P, Landreneau R, Dowling R et al. (1993) Comparison of open versus thoracoscopic lung biopsy for diffuse infiltrative pulmonary disease. J Thorac Cardiovasc Surg 106: 194–9.
Kadokura M, Colby T, Myers J et al. (1994) Pathological comparison of video-assisted thoracic surgical lung biopsy and traditional open lung biopsy. J Thorac Cardiovasc Surg 494: 8.
Krasna M, White C, Aisner S et al. (1995) The role of thoracoscopy in the diagnosis of interstitial lung disease. Ann Thorac Surg 59: 348–51.
Ray J III, Lawton B, Myers W et al. (1976) Open pulmonary biopsy. Nineteen-year experience with 416 consecutive operations. Chest 69: 43–7.
Wagner J, Stahler C, Knox S et al. (1992) Clinical utility of open lung biopsy for undiagnosed pul-monary infiltrates. Am J Surg 164: 104–7.
Lachapelle K, Morin J (1995) Benefit of open lung biopsy in patients with respiratory failure. Can J Surg 38: 316–21.
Thurlbeck/Miller, Muller/Rosenow (1991) Diffuse diseases of the lung: a team approach. Abnormal structure and function of the lung. BC Decker, Philadelphia, Pennsylvania.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag London Limited
About this chapter
Cite this chapter
Goodnight-White, S. (1999). Bronchoscopy and Surgical Procedures for Inspection and Biopsy. In: Sperber, M. (eds) Diffuse Lung Disorders. Springer, London. https://doi.org/10.1007/978-1-4471-3440-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3440-4_6
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3442-8
Online ISBN: 978-1-4471-3440-4
eBook Packages: Springer Book Archive